Managing the Fight against Onchocerciasis in Africa: APOC Experience.

Managing the Fight against Onchocerciasis in Africa: APOC Experience.

Saved in:

Bibliographic Details
Main Authors:	Grace Fobi, Laurent Yameogo, Mounkaila Noma, Yaovi Aholou, Joseph B Koroma, Honorat M Zouré, Tony Ukety, Paul-Samson Lusamba-Dikassa, Chris Mwikisa, Daniel A Boakye, Jean-Baptist Roungou
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2015-05-01
Series:	PLoS Neglected Tropical Diseases
Online Access:	https://journals.plos.org/plosntds/article/file?id=10.1371/journal.pntd.0003542&type=printable
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

40 Years of the APOC Partnership.
by: Jean-Baptist Roungou, et al.
Published: (2015-05-01)

Investing in Onchocerciasis Control: Financial Management of the African Programme for Onchocerciasis Control (APOC).
by: Donald A P Bundy, et al.
Published: (2015-05-01)

Community-directed distributors-The "foot soldiers" in the fight to control and eliminate neglected tropical diseases.
by: Uche V Amazigo, et al.
Published: (2021-03-01)

Identification of the onchocerciasis vector in the Kakoi-Koda focus of the Democratic Republic of Congo.
by: Rory J Post, et al.
Published: (2022-11-01)

The geographic distribution of Loa loa in Africa: results of large-scale implementation of the Rapid Assessment Procedure for Loiasis (RAPLOA).
by: Honorat Gustave Marie Zouré, et al.
Published: (2011-06-01)

Using Community-Level Prevalence of Loa loa Infection to Predict the Proportion of Highly-Infected Individuals: Statistical Modelling to Support Lymphatic Filariasis and Onchocerciasis Elimination Programs.
by: Daniela K Schlüter, et al.
Published: (2016-12-01)

The roles, signalling pathways and therapeutic implications of Apoc1 in cancer
by: Hao-Han Guo, et al.
Published: (2025-05-01)

Evaluation of Lymphatic Filariasis and Onchocerciasis in Three Senegalese Districts Treated for Onchocerciasis with Ivermectin.
by: Nana O Wilson, et al.
Published: (2016-12-01)

ANGPTL3, ANGPTL4, APOA5, APOB, APOC2, APOC3, LDLR, PCSK9, LPL gene variants and coronary artery disease risk
by: A. N. Meshkov, et al.
Published: (2022-11-01)

The onchocerciasis hypothesis of nodding syndrome.
by: Robert Colebunders, et al.
Published: (2023-08-01)

Onchocerciasis-associated epilepsy and biomarkers.
by: Robert Colebunders, et al.
Published: (2024-05-01)

Assessing the impact of complex health systems strengthening programs on maternal health care utilization in fragile and conflict-affected states: evidence from the Democratic Republic of the Congo
by: David R. Hotchkiss, et al.
Published: (2025-06-01)

Micronutrient and protein-energy supplementation enhance vaccine responses in undernourished children: Evidence from a systematic review [version 3; peer review: 2 approved, 1 not approved]
by: Paul-Samson Lusamba Dikassa, et al.
Published: (2025-07-01)

Onchocerciasis: Target product profiles of in vitro diagnostics to support onchocerciasis elimination mapping and mass drug administration stopping decisions.
by: Marco A Biamonte, et al.
Published: (2022-08-01)

Pancreatitis as a Main Consequence of APOC2-Related Hypertriglyceridemia: The Role of Nonsense and Frameshift Variants
by: Bahareh Rabbani, et al.
Published: (2024-01-01)

Experimental Therapeutics for Challenging Clinical Care of a Patient with an Extremely Rare Homozygous APOC2 Mutation
by: Masako Ueda, et al.
Published: (2020-01-01)

Spatial clustering of onchocerciasis in Bioko Island, Equatorial Guinea
by: Diana Gómez-Barroso, et al.
Published: (2018-11-01)

Knowledge and Practices of Four Onchocerciasis-Endemic Communities in Cameroon
by: Kamtsap Pierre, et al.
Published: (2025-03-01)

The Search for an Efficient Black Fly Trap for Xenomonitoring of Onchocerciasis
by: Kenneth B. Otabil, et al.
Published: (2018-01-01)

Predicting the environmental suitability for onchocerciasis in Africa as an aid to elimination planning.
by: Elizabeth A Cromwell, et al.
Published: (2021-07-01)

Continuous and pulsed epidemiological models for onchocerciasis with implications for eradication strategy
by: Glenn Ledder, et al.
Published: (2018-07-01)

The Impact of Onchocerciasis Elimination Measures in Africa: A Systematic Review
by: Policarpo Ncogo, et al.
Published: (2024-12-01)

Ivermectin as a promising therapeutic option for onchocerciasis‐associated epilepsy
by: Mohammad Amin Manavi, et al.
Published: (2025-02-01)

Acceptability of test and treat with doxycycline against Onchocerciasis in an area of persistent transmission in Massangam Health District, Cameroon.
by: Rogers Nditanchou, et al.
Published: (2023-04-01)

Entomological surveillance of onchocerciasis in Burkina Faso: Progress towards interrupting transmission in blackflies in the main river basins of the country
by: Lassane Koala, et al.
Published: (2025-01-01)

An Unexpected Cause of Eye Irritation: A Case of Zoonotic Ocular Onchocerciasis
by: Abhishek Biswas, et al.
Published: (2013-01-01)

Appraising Onchocerciasis Community Directed Treatment with Ivermectin: Problems, Progress and Prospects
by: Osue H.O.*
Published: (2023-06-01)

Global stability analysis and modelling onchocerciasis transmission dynamics with control measures
by: Musah Konlan, et al.
Published: (2024-12-01)

Repurposing auranofin as a lead candidate for treatment of lymphatic filariasis and onchocerciasis.
by: Christina A Bulman, et al.
Published: (2015-02-01)

The Spectrum of Ocular Diseases in the Onchocerciasis-Endemic Focus of Raga in South Sudan
by: Sube KL, et al.
Published: (2024-12-01)

Gallic acid alleviates ferroptosis by negatively regulating APOC3 and improves nerve function deficit caused by traumatic brain injury
by: Yu Liu, et al.
Published: (2025-03-01)

A phenomics-based strategy identifies loci on APOC1, BRAP, and PLCG1 associated with metabolic syndrome phenotype domains.
by: Christy L Avery, et al.
Published: (2011-10-01)

Insights and perspectives on the role of APOC1 inhibition in modulating immunotherapy outcomes in HCC: Commentary on Inhibition of APOC1 promotes the transformation of M2 into M1 macrophages via the ferroptosis pathway and enhances anti-PD1 immunotherapy in hepatocellular carcinoma based on single-cell RNA sequencing
by: Jiewen Wei
Published: (2025-06-01)

Progress towards elimination of onchocerciasis transmission in Mali: A "pre-stop MDA" survey in 18 transmission zones.
by: Housseini Dolo, et al.
Published: (2023-11-01)

Mathematical Modelling of the Spread and Control of Onchocerciasis in Tropical Countries: Case Study in Nigeria
by: Ikechukwu Chiwueze Oguoma, et al.
Published: (2014-01-01)

Onchocerciasis is not a major cause of blindness in two endemic villages in Sierra Leone
by: Ibrahim Kargbo-Labour, et al.
Published: (2025-01-01)

Uncertainty surrounding projections of the long-term impact of ivermectin treatment on human onchocerciasis.
by: Hugo C Turner, et al.
Published: (2013-01-01)

Correlation between Serum ApoC III and Galectin-3 Levels and Maternal and Neonatal Adverse Outcomes in Gestational Diabetes Mellitus Patients
by: Tingting Tang, et al.
Published: (2022-01-01)

<i>APOC1</i> rs445925 and rs4420638 polymorphic variants as genetic predictors of occlusive peripheral arterial disease of lower extremities
by: S. N. Zhabin, et al.
Published: (2024-11-01)

Retracted: Correlation between Serum ApoC III and Galectin-3 Levels and Maternal and Neonatal Adverse Outcomes in Gestational Diabetes Mellitus Patients
by: Emergency Medicine International
Published: (2024-01-01)